Literature DB >> 16479614

Cytokine analysis to predict immunosuppression.

Markus J Barten1, Axel Rahmel, József Bocsi, Andreas Boldt, Jens Garbade, Stefan Dhein, Friedrich W Mohr, Jan F Gummert.   

Abstract

BACKGROUND: Recently, it has been realized that TH1/TH2 cytokine production offer the unique possibility to predict drug efficacy. However, there is still an incessant need to explore assay conditions and techniques of analyzing cytokines, which are specific and reliable for monitoring drug efficacy.
METHODS: In this study we used the multiplex bead array technique to detect cytokines of TH1/TH2 cells in whole blood of heart transplanted (HTx) recipients.
RESULTS: We found significantly different levels of cytokine expression in HTx recipients compared with cytokine levels in patients prior to HTx. Furthermore, particular cytokine levels were significantly decreased 2 h after drug dosing, compared with cytokine levels before dosing in mitogen-stimulated whole blood.
CONCLUSIONS: Cytokine analysis with the multiplex array technique in mitogen-stimulated whole blood provides the possibility to predict immunosuppression. (c) 2006 International Society for Analytical Cytology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479614     DOI: 10.1002/cyto.a.20215

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  8 in total

1.  Cytomics emerging from cytometry.

Authors:  A Tárnok; G Brockhoff
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

2.  Effects of oral cyclosporine on canine T-cell expression of IL-2 and IFN-gamma across a 12-h dosing interval.

Authors:  C L Fellman; T M Archer; J V Stokes; R W Wills; K V Lunsford; A J Mackin
Journal:  J Vet Pharmacol Ther       Date:  2015-12-17       Impact factor: 1.786

3.  A Simple Microfluidic Platform for Long-Term Analysis and Continuous Dual-Imaging Detection of T-Cell Secreted IFN-γ and IL-2 on Antibody-Based Biochip.

Authors:  Dieudonné R Baganizi; Loïc Leroy; Loïc Laplatine; Stacie J Fairley; Samuel Heidmann; Samia Menad; Thierry Livache; Patrice N Marche; Yoann Roupioz
Journal:  Biosensors (Basel)       Date:  2015-12-04

4.  Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice.

Authors:  Zhiwei Zhang; Hua Sun; Jianhua Zhang; Chunlei Ge; Suwei Dong; Zhen Li; Ruilei Li; Xiaodan Chen; Mei Li; Yun Chen; Yingying Zou; Zhongyi Qian; Lei Yang; Jinyan Yang; Zhitao Zhu; Zhimin Liu; Xin Song
Journal:  Med Sci Monit       Date:  2016-09-02

5.  Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.

Authors:  Natalia Riva; Manuel Molina; Berta L Cornaló; María V Salvador; Andrea Savransky; Silvia Tenembaum; María M Katsicas; Marta Monteverde; Paulo Cáceres Guido; Marcela Rousseau; Raquel Staciuk; Agustín González Correas; Pedro Zubizarreta; Oscar Imventarza; Eduardo Lagomarsino; Eduardo Spitzer; Marcelo Tinelli; Paula Schaiquevich
Journal:  Front Pharmacol       Date:  2022-01-26       Impact factor: 5.810

6.  Optimal method to stimulate cytokine production and its use in immunotoxicity assessment.

Authors:  Wenchao Ai; Haishan Li; Naining Song; Lei Li; Huiming Chen
Journal:  Int J Environ Res Public Health       Date:  2013-08-27       Impact factor: 3.390

7.  In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes.

Authors:  Maciej Guzera; Lidia Szulc-Dąbrowska; Anna Cywińska; Joy Archer; Anna Winnicka
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

8.  Immune monitoring after pediatric liver transplantation - the prospective ChilSFree cohort study.

Authors:  Imeke Goldschmidt; André Karch; Rafael Mikolajczyk; Frauke Mutschler; Norman Junge; Eva Doreen Pfister; Tamara Möhring; Lorenzo d'Antiga; Patrick McKiernan; Deirdre Kelly; Dominique Debray; Valérie McLin; Joanna Pawlowska; Loreto Hierro; Kerstin Daemen; Jana Keil; Christine Falk; Ulrich Baumann
Journal:  BMC Gastroenterol       Date:  2018-05-16       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.